Asence Pharma Private Limited Revenue and Competitors
Estimated Revenue & Valuation
- Asence Pharma Private Limited's estimated annual revenue is currently $17.1M per year.
- Asence Pharma Private Limited's estimated revenue per employee is $201,000
Employee Data
- Asence Pharma Private Limited has 85 Employees.
- Asence Pharma Private Limited grew their employee count by 6% last year.
Asence Pharma Private Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | General Manager | Reveal Email/Phone |
3 | Assistant General Manager - Export | Reveal Email/Phone |
4 | asst. manager - contract mfg | Reveal Email/Phone |
5 | PA | Reveal Email/Phone |
Asence Pharma Private Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Asence Pharma Private Limited?
Asence INC. is a US-incorporated company that specializes in the supply of quality pharmaceutical preparations (Finished Dosage Forms and Active Pharmaceutical Ingredients) to international markets. At Asence our mission is to improve and enhance the quality of human life through supplying quality pharmaceutical preparations distributed globally via our vast infrastructure of international alliances.
keywords:N/AN/A
Total Funding
85
Number of Employees
$17.1M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.3M | 85 | -9% | N/A |
#2 | N/A | 85 | 8% | N/A |
#3 | $14.8M | 85 | 9% | N/A |
#4 | $20.7M | 85 | -16% | N/A |
#5 | $12.8M | 85 | 9% | N/A |